PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+5.09%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$166M
AUM Growth
+$166M
(+29%)
Cap. Flow
+$23M
Cap. Flow
% of AUM
13.88%
Top 10 Holdings %
Top 10 Hldgs %
36.43%
Holding
82
New
26
Increased
17
Reduced
11
Closed
16
Top Buys
| 1 |
Universal Health Services
UHS
|
$8.71M |
| 2 |
Pfizer
PFE
|
$5.14M |
| 3 |
Stryker
SYK
|
$5.11M |
| 4 |
SPNC
Spectranetics Corp
SPNC
|
$4.28M |
| 5 |
AbbVie
ABBV
|
$4.02M |
Top Sells
| 1 |
Baxter International
BAX
|
$9.93M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
$5.3M |
| 3 |
Boston Scientific
BSX
|
$5.03M |
| 4 |
Humana
HUM
|
$4.9M |
| 5 |
CONMED
CNMD
|
$4.72M |
Sector Composition
| 1 | Healthcare | 83.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cigna
CI
$80.3B
| $9.36M | 4.79% | 65,000 +26,000 | +67% | +$3.75M |
|
|
2
Universal Health Services
UHS
$11.6B
| $8.71M | 4.46% | +60,000 | New | +$8.71M |
|
3
Teleflex
TFX
$5.59B
| $6.54M | 3.35% | 48,800 +13,800 | +39% | +$1.85M |
|
|
ALIM
4
DELISTED
Alimera Sciences, Inc.
ALIM
| $6M | 3.07% | 1,243,807 +127,816 | +11% | +$616K |
|
|
SIEN
5
DELISTED
Sientra, Inc.
SIEN
| $5.61M | 2.87% | 241,402 -31,698 | -12% | -$737K |
|
|
NUVA
6
DELISTED
NuVasive, Inc.
NUVA
| $5.18M | 2.65% | 94,139 +14,339 | +18% | +$789K |
|
|
7
Pfizer
PFE
$141B
| $5.14M | 2.63% | +142,500 | New | +$5.14M |
|
|
8
Stryker
SYK
$150B
| $5.11M | 2.62% | +50,000 | New | +$5.11M |
|
9
Cooper Companies
COO
$13.4B
| $4.43M | 2.26% | 25,000 +10,000 | +67% | +$1.77M |
|
|
SPNC
10
DELISTED
Spectranetics Corp
SPNC
| $4.28M | 2.19% | +250,000 | New | +$4.28M |
|
|
11
Boston Scientific
BSX
$156B
| $4.08M | 2.09% | 235,000 -290,000 | -55% | -$5.03M |
|
|
12
AbbVie
ABBV
$372B
| $4.02M | 2.06% | +57,375 | New | +$4.02M |
|
13
Smith & Nephew
SNN
$16.3B
| $3.89M | 1.99% | 105,000 -17,500 | -14% | -$648K |
|
14
Edwards Lifesciences
EW
$47.8B
| $3.8M | 1.95% | 25,000 -15,000 | -38% | -$2.28M |
|
15
Vanda Pharmaceuticals
VNDA
$279M
| $3.76M | 1.93% | 307,500 +227,117 | +283% | +$2.78M |
|
|
NXTM
16
DELISTED
NxStage Medical Inc.
NXTM
| $3.72M | 1.9% | 260,200 +156,084 | +150% | +$2.23M |
|
17
Owens & Minor
OMI
$378M
| $3.69M | 1.89% | +105,000 | New | +$3.69M |
|
|
CYBX
18
DELISTED
CYBERONICS INC
CYBX
| $3.68M | 1.89% | 60,000 +30,000 | +100% | +$1.84M |
|
19
Jazz Pharmaceuticals
JAZZ
$7.75B
| $3.46M | 1.77% | 18,000 -14,500 | -45% | -$2.79M |
|
20
Insulet
PODD
$23.9B
| $3.39M | 1.73% | 100,000 -70,900 | -41% | -$2.4M |
|
|
CPHD
21
DELISTED
Cepheid Inc
CPHD
| $3.34M | 1.71% | +60,000 | New | +$3.34M |
|
22
Bristol-Myers Squibb
BMY
$96B
| $3.32M | 1.7% | +50,625 | New | +$3.32M |
|
23
Perrigo
PRGO
$3.27B
| $3.29M | 1.68% | +17,125 | New | +$3.29M |
|
|
AFFX
24
DELISTED
AFFYMETRIX INC
AFFX
| $3.29M | 1.68% | 300,000 +169,883 | +131% | +$1.86M |
|
25
Bausch Health
BHC
$2.74B
| $3.22M | 1.65% | 12,500 -9,500 | -43% | -$2.45M |
|